We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Thyroid Tests Overused During Psychiatric Admissions

By LabMedica International staff writers
Posted on 22 Dec 2011
A new study suggests that screening for thyroid-stimulating hormone (TSH) is done both too often and unnecessarily when patients are admitted for psychiatric evaluation.

Researchers at Waterbury Hospital (Waterbury, CT, USA) conducted a chart review for 98 patients (83% of whom had a previous psychiatric history) to examine the appropriateness of measuring TSH levels in patients under evaluation because of behavioral disturbances, even if there are no other clinical signs or symptoms suggesting thyroid dysfunction. More...
In all, TSH screening was ordered for 66.3% of the adult patients admitted to an inpatient psychiatry unit during one eight-week period.

The results showed that 97% of those tests turned out to be within the normal range, with only two patients whose TSH levels were outside the normal range, of whom one was elevated and one was low. When the admission diagnoses among patients who had undergone TSH screening and those who had not were considered, depression was identified in 26 and 7 patients, respectively. There was no difference in the length of hospital stay in the TSH group and the non-TSH group, with a mean stay of 9.5 days. Nine patients in the TSH group and eight in the non-TSH group had also undergone screening within the previous six months. The study was presented as a poster session at the midyear clinical meeting of the American Society of Health-System Pharmacists (ASHP), held during December 2011 in New Orleans (LA, USA).

“Routine TSH screening should not be done for patients with a long history of psychiatric disease, as was the case in most of our patients, and especially if a previous level has been obtained recently,” said lead author and study presenter Kelly Shepard, PharmD. “We have many patients with frequent readmissions. The test can be useful for patients with a first admission, but is unnecessary in patients with a 10-year history of disease.”

Both hyper- and hypothyroidism are recognized as potential contributors to psychiatric illness, with psychosis being specifically included in the diagnostic criteria for thyroid storm. In addition, the US Endocrine Society (Chevy Chase, MD, USA) guidelines state that thyrotoxicosis, with a TSH level below 0.01 mU/L, can cause alterations in psychiatric and neuropsychological function. Depression also has been linked with thyroid dysfunction, particularly among patients with previously recognized thyroid abnormalities.

Related Links:
Waterbury Hospital
US Endocrine Society


Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Rapid Flu Test
Influenza A&B Rapid Test Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.